Annuncio pubblicitario
Italia markets closed
  • Dow Jones

    41.145,02
    +190,54 (+0,47%)
     
  • Nasdaq

    18.042,55
    -466,79 (-2,52%)
     
  • Nikkei 225

    41.097,69
    -177,39 (-0,43%)
     
  • EUR/USD

    1,0931
    +0,0029 (+0,26%)
     
  • Bitcoin EUR

    59.289,32
    -145,65 (-0,25%)
     
  • CMC Crypto 200

    1.354,76
    +12,43 (+0,93%)
     
  • HANG SENG

    17.739,41
    +11,43 (+0,06%)
     
  • S&P 500

    5.598,95
    -68,25 (-1,20%)
     

AMBU FINANCIAL CALENDAR FOR 2023/24

Ambu A/S
Ambu A/S

This financial calendar lists the expected release dates of Ambu’s financial announcements for the financial year 2023/24, as well as the date of Ambu’s Annual General Meeting. 

2023

8 NOVEMBER 2023

Annual Report 2022/23

13 DECEMBER 2023

Annual General Meeting 2023


2024

30 JANUARY 2024

Earnings release Q1 2023/24

14 MAY 2024

Earnings release Q2 2023/24

30 AUGUST 2024

Earnings release Q3 2023/24

30 SEPTEMBER 2024

End of fiscal year 2023/24

5 NOVEMBER 2024

Annual Report 2023/24

4 DECEMBER 2024

Annual General Meeting 2024


The deadline for the inclusion of specific items on the agenda for the Annual General Meeting 2023 is 31 October 2023.

ANNUNCIO PUBBLICITARIO



Ambu A/S
Baltorpbakken 13
2750 Ballerup
Denmark
Tel. +45 7225 2000
CVR no.: 63 64 49 19
www.Ambu.com


CONTACT INFORMATION

Media
Tine Bjørn Schmidt
Head of Corporate Communications
tisc@ambu.com
+45 2264 0697

Investors
Anders Hjort
Head of Investor Relations
anhj@ambu.com
+45 2892 8881


ABOUT AMBU
Since 1937, Ambu has been rethinking solutions, together with healthcare professionals, to save lives and improve patient care. Today, millions of patients and healthcare professionals worldwide depend on the efficiency, safety and performance of our single-use endoscopy, anaesthesia and patient monitoring solutions. Headquartered near Copenhagen in Denmark, Ambu employs around 4,500 people in Europe, North America, Latin America and Asia Pacific. For more information, please visit Ambu.com.

Attachment